Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 41, 3172-3178, August 1, 1981]
© 1981 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huseby, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huseby, R. A.

Effects of Cryptorchidy, Parabiosis, and Estrogen Administration upon Leydig Cell Tumorigenesis in Fischer Rats1

Robert A. Huseby2

AMC Cancer Research Center and Hospital, Lakewood, Colorado 80214, and the Oncology Research Laboratory, Department of Medicine, Henry Ford Hospital, Detroit, Michigan 48202

The effects on Leydig cell tumorigenesis of surgical cryptorchidy, parabiotic union with a castrate male partner, and a combination of the two procedures as well as of the continuous exposure to a high level of diethylstilbestrol stimulation were studied in the high-tumor Fischer rat. Localized foci of adenomatous hyperplasia were found to have developed in the scrotal testes of most animals by 13.5 months of age. Parabiosis with a castrate male partner did not appear to alter the process significantly, but surgical cryptorchidy, even when combined with parabiosis, completely prevented the development of this pretumorous lesion as did the chronic administration of diethylstilbestrol. Furthermore, intraabdominal residency throughout the life span of animals was found to inhibit Leydig cell tumor formation almost completely. Comparative end organ weights as well as plasma testosterone determinations reported earlier indicated that, with continued intraabdominal residency 3 months and longer, the Leydig cells in this strain of rat became significantly less responsive to stimulation by pituitary gonadotropic hormones.

The data are interpreted as indicating that the endocrine stimuli most centrally involved in the genesis of this tumor type are quite different in the mouse and the rat, an abnormal response to gonadotropic stimulation being pivotal in the rat while reaction to estrogens is the most significant factor in the mouse.

1 This research was initiated under USPHS Contract PH 43-62-171 from the Cancer Chemotherapy National Service Center and continued with the aid of USPHS Research Grant CA 05191 from the National Cancer Institute and by a grant from the Matilda R. Wilson Fund.

2 To whom requests for reprints should be addressed, at Department of Medicine, Henry Ford Hospital, Detroit, Mich. 48202.

Received 12/18/80. Accepted 5/11/81.




This article has been cited by other articles:


Home page
Biol. Reprod.Home page
S. Schubert, K. Kamino, D. Bohm, I. Adham, W. Engel, R. v. Wasielewski, D. Moharregh-Khiabani, G. Mauceri, B. Vaske, A. Meinhardt, et al.
TSPY Expression Is Variably Altered in Transgenic Mice with Testicular Feminization
Biol Reprod, July 1, 2008; 79(1): 125 - 133.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1981 by the American Association for Cancer Research.